Primary Hyperparathyroidism (PHPT)

DBCOND0050000Endocrine System DiseasesNutritional and Metabolic Diseases

Primary Hyperparathyroidism (PHPT) is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Also known as
Hyperparathyroidism, Primary · Hyperparathyroidism primary · Primary Hyperparathyroidism · Parathyroid Hyperplasia · primary hyperparathyroidism (HPT)
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0471516ICD-10E21.0SNOMED CT190452007MedDRA10020707UMLSC0221002

What you can answer from here — as of October 20, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
36Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Drug reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Primary Hyperparathyroidism (PHPT) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In